Table 1.
Characteristics | EATL type 1 | EATL type 2 | variant type EATL | AIE-associated T-cell lymphoma |
---|---|---|---|---|
Association with enteropathy | + | − | + | + |
HLA-DQ2/-DQ8 | + | − | + | + |
Putative precursor cell | CD3s−IEL | Clonal aberrant T-cell | Clonal γδ-T-cells | Clonal CD8 αβ-T-cells |
Morphology | Polymorphic | Monomorphic | Polymorphic | Monomorphic |
Phenotype | ||||
CD3 | + | + | − | + |
CD4 | Mostly− | − | − | − |
CD5 | Mostly− | Mostly+(70%) | − | + |
CD8 | Mostly−(20%+) | + | − | + |
CD7 | + | + | + | − |
CD15 | − | − | + | nd |
CD20 | − | − | − | − |
CD30 | Mostly+(80%) | − | + | +/− |
CD56 | − | + | − | − |
Granzyme | + | + | + | + |
TIA1 | + | + | + | + |
Chromosomal aberrantions | ||||
Gains | 1q, 5q, 7q, 9q, | MYC, 7q, 8q, 9q | 7q | 7q |
Loss | 8p, 13q,16q | 8p, 10q |
HLA, human leucocyte antigen.